🇺🇸 FDA

Intelligence · Clinical Pipeline

Approved programs Pipeline Programs

ClinicalTrials.gov programs marked approved or launched in registry data.

Programs
1,839

Quick answer

NovaPharmaNews tracks 1,839 approved programs pharmaceutical pipeline programs from ClinicalTrials.gov. ClinicalTrials.gov programs marked approved or launched in registry data.

Top sponsors

Page 3 of 39

  1. Aflibercept

    Regeneron UK Limited

    Age Related Macular Degeneration

    approved small molecule active

    1 trial

  2. Aflibercept

    Regeneron UK Limited

    Fibrovascular Pigment Epithelial Detachment

    approved small molecule terminated

    1 trial

  3. Aflibercept

    Regeneron UK Limited

    Submacular Vascularized Pigment Epithelial Detachments

    approved small molecule completed

    1 trial

  4. Aflibercept

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials

  5. Aflibercept

    Regeneron UK Limited

    Retinal Vein Occlusion

    approved small molecule active

    2 trials

  6. Aflibercept

    Regeneron UK Limited

    Exudative Macular Degeneration

    approved small molecule completed

    1 trial

  7. Aflibercept

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    2 trials

  8. Aflibercept (2.0 mg)

    Regeneron UK Limited

    Macular Edema With Central Retinal Vein Occlusions

    approved small molecule completed

    1 trial

  9. Aflibercept (BAY86-5321, Eylea)

    Regeneron UK Limited

    Diabetic Macular Edema

    approved small molecule completed

    1 trial

  10. Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  11. Aflibercept (Eylea, VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Neovascular Macular Degeneration

    approved small molecule completed

    1 trial

  12. Aflibercept 8 mg (VEGF Trap-Eye, BAY86-5321)

    Regeneron UK Limited

    Diabetic Macular Edema (DME)

    approved small molecule active

    1 trial

  13. Aflibercept Injection

    Regeneron UK Limited

    Diabetic Retinopathy

    approved small molecule completed

    2 trials

  14. Aflibercept Ophthalmic

    Regeneron UK Limited

    Wet Macular Degeneration

    approved small molecule completed

    1 trial

  15. AirDuo Digihaler

    Teva Pharma GmbH

    Asthma

    approved other completed

    1 trial

  16. Albendazole

    United Therapeutics Europe Ltd

    Ascariasis

    approved small molecule completed

    1 trial

  17. Albuterol eMDPI DS

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  18. Albuterol-HFA-MDI

    Teva Pharma GmbH

    Asthma

    approved small molecule completed

    1 trial

  19. Alcohol Wipes vs. No Alcohol Wipes

    Teva Pharma GmbH

    Multiple Sclerosis

    approved other completed

    1 trial

  20. Alcohol injection

    The University of Hong Kong

    Malignancy

    approved small molecule active

    1 trial

  21. Aldurazyme (Recombinant Human Alpha-L-Iduronidase)

    BioMarin Pharmaceutical Australia Pty Ltd

    Mucopolysaccharidosis I

    approved mab completed

    3 trials

  22. Alecensa 150 mg hard capsules

    Disc Medicine

    ALK positive non-small cell lung cancer

    approved small molecule active

    1 trial

  23. Alendronate

    Hospital Authority, Hong Kong

    Non-Traumatic Osteonecrosis

    approved small molecule active

    1 trial

  24. Alendronate

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Osteogenesis Imperfecta

    approved small molecule completed

    1 trial

  25. Alfacalcidol

    Teva Pharma GmbH

    Accidental Falls

    approved small molecule terminated

    1 trial

  26. Algorithm Treatment

    BRIGHT MINDS BIOSCIENCES INC.

    HIV

    approved small molecule completed

    1 trial

  27. Alirocumab

    Regeneron UK Limited

    Myocardial Infarction

    approved small molecule terminated

    2 trials

  28. Alirocumab

    Regeneron UK Limited

    Atherosclerosis

    approved small molecule active

    1 trial

  29. Alirocumab

    Regeneron UK Limited

    Dyslipidemia

    approved small molecule completed

    1 trial

  30. Alirocumab 150 MG/ML subcutaneous injection

    Regeneron UK Limited

    Saphenous Vein Graft Atherosclerosis

    approved small molecule terminated

    1 trial

  31. Alirocumab SAR236553

    Regeneron UK Limited

    Hypercholesterolemia

    approved small molecule completed

    1 trial

  32. Alirocumab, Placebo product for REGN727

    The George Institute

    Cardiac allograft vaculopathy in recent heart transplant recipients

    approved small molecule active

    1 trial

  33. Aliskiren

    Novartis Pharmaceuticals

    Hypertension

    approved small molecule completed

    1 trial

  34. Aliskiren

    United Therapeutics Europe Ltd

    IgA Nephropathy

    approved small molecule completed

    1 trial

  35. Allopurinol Tablet 300 mg

    Hospital Authority, Hong Kong

    Kidney Calculi

    approved small molecule completed

    1 trial

  36. Almax Forte 1,5 g suspensión oral

    Almirall, S.A.

    heartburn and or reflux

    approved small molecule active

    1 trial

  37. Alofisel 5 × 106 cells/mL dispersion for injection.

    Takeda

    Perianal fistulising Crohn´s disease

    approved small molecule active

    1 trial

  38. Alogliptin

    Takeda

    Diabetes Mellitus, Type 2

    approved small molecule completed

    6 trials

  39. Alpha1-Proteinase Inhibitor

    Takeda

    Alpha 1-Antitrypsin Deficiency

    approved mab completed

    1 trial

  40. Alpha1-proteinase inhibitor

    Takeda

    Alpha1-antitrypsin Deficiency

    approved mab completed

    1 trial

  41. Alprostadil

    The First People's Hospital of Lianyungang

    Stroke

    approved small molecule active

    1 trial

  42. Amantadine

    BRIGHT MINDS BIOSCIENCES INC.

    Cocaine-Related Disorders

    approved small molecule completed

    3 trials

  43. Ambulatory Oxygen

    United Therapeutics Europe Ltd

    Lung; Disease, Fibroid (Chronic)

    approved small molecule completed

    1 trial

  44. Amiodarone Hikma 50 mg/ml soluzione iniettabile, BUPISEN 5 mg/ml soluzione iniettabile, Lidocaina Kabi 20 mg/ml soluzione iniettabile

    Fondazione Telethon ETS

    electrical storm

    approved small molecule active

    1 trial

  45. Amiodarone hydrochloride 200 mg tablets

    The George Institute

    Persistent atrial fibrillation

    approved small molecule active

    1 trial

  46. Amlodipine besylate

    The First People's Hospital of Lianyungang

    Hypertension

    approved small molecule active

    1 trial

  47. Amlodipine besylate/atorvastatin calcium single pill combination

    Pfizer

    Hypertension

    approved small molecule completed

    1 trial

  48. Amlodipine, Telmisartan, Amiloride Compound , Simvastatin

    Chinese University of Hong Kong

    Essential Hypertension

    approved small molecule active

    1 trial

Frequently asked questions

How many Approved programs pipeline programs are in the directory?

1,839 published programs match this development stage in our ClinicalTrials.gov index.

What defines this pipeline stage?

Phase and status reflect ClinicalTrials.gov registry fields at last sync. See our clinical trial phases reference for methodology.

Data attribution: Data sources · All pipeline programs

Drug approvals, clinical trials, M&A, event intelligence, and company updates — weekly.

Customize topics & region
Topics
Region

No spam. Unsubscribe anytime. See our privacy policy.